Auswahl der wissenschaftlichen Literatur zum Thema „GlucoCEST“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "GlucoCEST" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "GlucoCEST"
Jin, Tao, Hunter Mehrens, Kristy S. Hendrich und Seong-Gi Kim. „Mapping Brain Glucose Uptake with Chemical Exchange-Sensitive Spin-Lock Magnetic Resonance Imaging“. Journal of Cerebral Blood Flow & Metabolism 34, Nr. 8 (28.05.2014): 1402–10. http://dx.doi.org/10.1038/jcbfm.2014.97.
Der volle Inhalt der QuelleBender, Benjamin, Kai Herz, Anagha Deshmane, Vivien Richter, Ghazaleh Tabatabai, Jens Schittenhelm, Marco Skardelly et al. „GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas“. Magnetic Resonance Materials in Physics, Biology and Medicine 35, Nr. 1 (10.12.2021): 77–85. http://dx.doi.org/10.1007/s10334-021-00982-5.
Der volle Inhalt der QuelleKim, Mina, Afroditi Eleftheriou, Luca Ravotto, Bruno Weber, Michal Rivlin, Gil Navon, Martina Capozza et al. „What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report“. Magnetic Resonance Materials in Physics, Biology and Medicine 35, Nr. 1 (15.01.2022): 87–104. http://dx.doi.org/10.1007/s10334-021-00994-1.
Der volle Inhalt der QuelleKim, Mina, Francisco Torrealdea, Sola Adeleke, Marilena Rega, Vincent Evans, Teresita Beeston, Katerina Soteriou et al. „Challenges in glucoCEST MR body imaging at 3 Tesla“. Quantitative Imaging in Medicine and Surgery 9, Nr. 10 (Oktober 2019): 1628–40. http://dx.doi.org/10.21037/qims.2019.10.05.
Der volle Inhalt der QuelleNasrallah, Fatima A., Guilhem Pagès, Philip W. Kuchel, Xavier Golay und Kai-Hsiang Chuang. „Imaging Brain Deoxyglucose Uptake and Metabolism by Glucocest MRI“. Journal of Cerebral Blood Flow & Metabolism 33, Nr. 8 (15.05.2013): 1270–78. http://dx.doi.org/10.1038/jcbfm.2013.79.
Der volle Inhalt der QuelleKentrup, Dominik, Annika Busch, Helga Pawelski, Eberhard Schlatter, Verena Hoerr und Stefan Reuter. „SP772NON-INVASIVE DETECTION OF ACUTE RENAL ALLOGRAFT REJECTION THROUGH GLUCOCEST MRI“. Nephrology Dialysis Transplantation 30, suppl_3 (Mai 2015): iii632. http://dx.doi.org/10.1093/ndt/gfv201.05.
Der volle Inhalt der QuelleColgan, Niall, Matthew Donoghue, Zdzislaw Zuchora, Brendan Tuohy und Wil van der Putten. „Investigation of GlucoCEST as novel clinical MR biomarker of glucose metabolism“. Physica Medica 32, Nr. 7 (Juli 2016): 959. http://dx.doi.org/10.1016/j.ejmp.2016.05.048.
Der volle Inhalt der QuelleXu, Xiang, Jiadi Xu, Kannie W. Y. Chan, Jing Liu, Huanling Liu, Yuguo Li, Lin Chen, Guanshu Liu und Peter C. M. van Zijl. „GlucoCEST imaging with on-resonance variable delay multiple pulse (onVDMP) MRI“. Magnetic Resonance in Medicine 81, Nr. 1 (29.07.2018): 47–56. http://dx.doi.org/10.1002/mrm.27364.
Der volle Inhalt der QuelleKentrup, Dominik, Philipp Bovenkamp, Annika Busch, Katharina Schuette-Nuetgen, Helga Pawelski, Hermann Pavenstädt, Eberhard Schlatter et al. „GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection“. Kidney International 92, Nr. 3 (September 2017): 757–64. http://dx.doi.org/10.1016/j.kint.2017.04.015.
Der volle Inhalt der QuelleXu, Xiang, Jiadi Xu, Linda Knutsson, Jing Liu, Huanling Liu, Yuguo Li, Bachchu Lal et al. „The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma“. Magnetic Resonance in Medicine 81, Nr. 6 (22.02.2019): 3798–807. http://dx.doi.org/10.1002/mrm.27683.
Der volle Inhalt der QuelleDissertationen zum Thema "GlucoCEST"
Delebarre, Thaddée. „Development of fast and robust metabolic imaging in humans at high magnetic field“. Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPAST001.
Der volle Inhalt der QuelleChemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST MRI) represents a powerful tool for the study of metabolism, offering superior temporal and spatial resolution as well as increased sensitivity compared to Magnetic Resonance Spectroscopy (MRS). CEST MRI enables the indirect detection of certain metabolites through the interaction between their labile protons and those of bulk water. CEST can map glucose, glutamate, creatine, which are important metabolites involved in cancers, and neurodegenerative and musculoskeletal diseases, representing therefore a promising bioimaging tool. The rapid development of high magnetic field MRI ((≥7 T) in recent decades greatly benefits CEST, opening up new applications and generating growing interest.The aim of this thesis is to develop CEST MRI in a clinical context, taking full advantage of high magnetic fields to increase the robustness and speed of CEST acquisitions. To this end, we focus on two main objectives. The first is to develop the CEST imaging method in a clinical environment, overcoming the practical limitations associated with high-field clinical MRI scanners, notably the strict constraints of Specific Absorption Rate (SAR) and RadioFrequency (RF) field heterogeneities (B1).To achieve this first objective, a parallel transmission CEST sequence was developed. Parallel transmission uses a multi-channel RF transmit antenna, which can be controlled independently to reduce B1 heterogeneity. Moreover, parallel transmission also allows optimized energy management using virtual observation points (a strategy developed in the laboratory) By making use of parallel transmission we have implemented an acquisition strategy which allowed us to produce CEST images with three times less B1 heterogeneity, and two times faster than compared to the state of the art literature reports.The second objective is to evaluate the performance of CEST, glucose, and glutamate weighted, in detecting and characterizing normal and pathological aging. A clinical study was carried out, involving young and elderly healthy volunteers as well as Alzheimer’s disease (AD) patients. The results showed that CEST can detect global variations in glutamate and glucose in the brain associated with aging. The acquisition and exploitation of data from AD patients is still in progress.In conclusion, this thesis has enabled the development of high-field CEST methods and the evaluation of their performance in the study of aging. These results open up encouraging prospects for the use of CEST as a biomarker of AD and other neurodegenerative diseases
Bücher zum Thema "GlucoCEST"
Hogg und European Society Of Pneumology. Glucocort Inflam Bronch Hyper: (Current Clinical Practice). Elsevier Science & Technology, 1985.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "GlucoCEST"
Torrealdea, Francisco, Marilena Rega und Xavier Golay. „Chapter 17 GlucoCEST: Imaging Glucose in Tumors“. In Chemical Exchange Saturation Transfer Imaging, 399–426. Penthouse Level, Suntec Tower 3, 8 Temasek Boulevard, Singapore 038988: Pan Stanford Publishing, 2017. http://dx.doi.org/10.1201/9781315364421-18.
Der volle Inhalt der Quelle